CAR T-Cell Therapy for Myeloma: Overview and Benefits

Chimeric antigen receptor (CAR) T-Cell therapy is a cutting-edge, personalized treatment for myeloma that uses your own T-cells to target cancer. The process involves collecting and modifying your T-cells, followed by infusion and close monitoring.   CAR-T is highly effective, especially for patients who may not qualify for stem cell transplants, and often provides a treatment break.  While side effects like cytokine release syndrome and neurotoxicity are possible, they are usually temporary and manageable.  Support resources are available to help with care, logistics, and recovery.